Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
Dasatinib resensitizes BRAF/MEK inhibitor efficacy in patient-derived xenografts from patients with progression on BRAF/MEK inhibitor treatment.
PMID 41704766 · PMC12907876 · iScience · 2026 · 8 claims · 6 setups
Genomic mutation and copy-number status show weak correlation with total/phospho-protein expression and pathway activation in melanoma PDX and TCGA samples
-
Full-text index only
Somatic mutation of epidermal growth factor receptor in a small subset of cutaneous squamous cell carcinoma.
PMID 19812598 · PMC2825112 · The Journal of investigative dermatology · 2010 · 8 claims · 5 setups
EGFR is activated by somatic mutation in a small subset of cutaneous SCC
-
Full-text index only
Pan-cancer evaluation of regulated cell death to predict overall survival and immune checkpoint inhibitor response.
PMID 38538696 · PMC10973470 · NPJ precision oncology · 2024 · 8 claims · 8 setups
RCD score, defined as the sum of ssGSEA scores of 18 RCD signatures, quantifies overall RCD signaling in a sample
-
Full-text index only
Robust and efficient annotation of cell states through gene signature scoring.
PMID 41708334 · PMC12951948 · Genome research · 2026 · 8 claims · 8 setups
Established scoring methods (Seurat, SCANPY, UCell, JASMINE) fail to provide robust and comparable score distributions across diverse signatures and experimental conditions, precluding accurate unsupervised cell-state annotation.
-
Full-text index only
Confounding factors in assessing the enriched expression of somatic mutant alleles in bulk tumor samples.
PMID 41781335 · PMC13138019 · Genome research · 2026 · 8 claims · 8 setups
Mutation-based ASE detection in bulk tumor samples can be confounded by gene expression differences between tumor and normal cells, producing apparent enrichment of the mutant allele in RNA without true ASE.